Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S6.53
P/E—
Fwd P/E20.69
PEG4.40
52W— – —
RSI—
Target$270.59 (+1.9%)
Beta0.23
Div1.96%
Loading chart…
RSI (14)
Loading patterns…
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 63
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
5Bullish
0Bearish
0Neutral
▲ Double Bottom — Two lows ~$220.81 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$219.98 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$224.17 — bullish reversal confirmed
▲ Bull Flag — Breakout after +14% pole — bullish continuation
▲ Bull Flag — Breakout after +13% pole — bullish continuation
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$270.59
+1.9% upside
Low $190
—
High $305
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| Guggenheim | Buy | — | ↔ Reiterate | 2026-07-17 |
| Raymond James | Outperform | — | ↔ Maintain | 2026-07-16 |
| RBC Capital | Outperform | — | ↔ Reiterate | 2026-07-16 |
| Wells Fargo | Overweight | — | ↔ Maintain | 2026-07-16 |
| Morgan Stanley | Overweight | — | ↔ Maintain | 2026-07-16 |
| TD Cowen | Buy | — | ↔ Maintain | 2026-07-13 |
| B of A Securities | Neutral | — | ↔ Maintain | 2026-07-10 |
| Citigroup | Buy | — | ↔ Maintain | 2026-07-08 |
| Leerink Partners | Outperform | Market Perform → Outperform | ▲ Upgrade | 2026-05-13 |
| Barclays | Equal-Weight | — | ↔ Maintain | 2026-04-15 |
| Stifel | Hold | — | ↔ Maintain | 2026-04-15 |
| HSBC | Buy | — | ↔ Maintain | 2026-03-17 |
| JP Morgan | Neutral | — | ↔ Maintain | 2026-03-05 |
| Freedom Capital Markets | Hold | — | ↔ Maintain | 2026-01-27 |
| Freedom Broker | Hold | — | ↔ Maintain | 2026-01-27 |
| Scotiabank | Sector Outperform | — | ↔ Maintain | 2026-01-22 |
| Bernstein | Market Perform | — | ↔ Maintain | 2026-01-09 |
| Goldman Sachs | Buy | — | ↔ Maintain | 2025-12-19 |
Guggenheim
2026-07-17
Buy
↔ Reiterate
Raymond James
2026-07-16
Outperform
↔ Maintain
RBC Capital
2026-07-16
Outperform
↔ Reiterate
Wells Fargo
2026-07-16
Overweight
↔ Maintain
Morgan Stanley
2026-07-16
Overweight
↔ Maintain
TD Cowen
2026-07-13
Buy
↔ Maintain
B of A Securities
2026-07-10
Neutral
↔ Maintain
Citigroup
2026-07-08
Buy
↔ Maintain
Leerink Partners
2026-05-13
Outperform
(from Market Perform)
▲ Upgrade
Barclays
2026-04-15
Equal-Weight
↔ Maintain
Stifel
2026-04-15
Hold
↔ Maintain
HSBC
2026-03-17
Buy
↔ Maintain
JP Morgan
2026-03-05
Neutral
↔ Maintain
Freedom Capital Markets
2026-01-27
Hold
↔ Maintain
Freedom Broker
2026-01-27
Hold
↔ Maintain
Scotiabank
2026-01-22
Sector Outperform
↔ Maintain
Bernstein
2026-01-09
Market Perform
↔ Maintain
Goldman Sachs
2025-12-19
Buy
↔ Maintain
Profitability
Gross Margin
68.14%TTM
Op. Margin
29.19%TTM
ROE
25.74%TTM
Rev. Growth
6.60%YoY
Free Cash Flow
16.89BTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
57.71MRQ
Current Ratio
1.09MRQ
Cash
20.76BMRQ
Total Debt
49.04BMRQ
Net Debt
—MRQ
Income
Div. Yield
1.96%TTM
Annual Rate
5.36Fwd
Payout Ratio
60.79%TTM
Dividend History
Payout Ratio (TTM): 60.79%
| Date | Amount / Share | Yield at Payment |
|---|---|---|
| 2026-05-26 | $1.3400 | 0.58% |
| 2026-02-24 | $1.3000 | 0.53% |
| 2025-11-25 | $1.3000 | 0.64% |
| 2025-08-26 | $1.3000 | 0.75% |
| 2025-05-27 | $1.3000 | 0.87% |
| 2025-02-18 | $1.2400 | 0.83% |
| 2024-11-26 | $1.2400 | 0.84% |
| 2024-08-27 | $1.2400 | 0.80% |
| 2024-05-20 | $1.2400 | 0.87% |
| 2024-02-16 | $1.1900 | 0.81% |
| 2023-11-20 | $1.1900 | 0.85% |
| 2023-08-25 | $1.1900 | 0.78% |
| 2023-05-22 | $1.1900 | 0.83% |
| 2023-02-17 | $1.1300 | 0.78% |
| 2022-11-21 | $1.1300 | 0.71% |
| 2022-08-22 | $1.1300 | 0.75% |
| 2022-05-23 | $1.1300 | 0.71% |
| 2022-02-18 | $1.0600 | 0.73% |
| 2021-11-22 | $1.0600 | 0.76% |
| 2021-08-23 | $1.0600 | 0.68% |
| 2021-05-24 | $1.0600 | 0.71% |
| 2021-02-22 | $1.0100 | 0.72% |
| 2020-11-23 | $1.0100 | 0.82% |
| 2020-08-24 | $1.0100 | 0.78% |
| 2020-05-22 | $1.0100 | 0.83% |
| 2020-02-24 | $0.9500 | 0.77% |
| 2019-11-25 | $0.9500 | 0.83% |
| 2019-08-26 | $0.9500 | 0.90% |
| 2019-05-24 | $0.9500 | 0.83% |
| 2019-02-25 | $0.9000 | 0.81% |
| 2018-11-26 | $0.9000 | 0.78% |
| 2018-08-27 | $0.9000 | 0.83% |
| 2018-05-25 | $0.9000 | 0.92% |
| 2018-02-26 | $0.8400 | 0.80% |
| 2017-11-27 | $0.8400 | 0.77% |
| 2017-08-25 | $0.8400 | 0.81% |
| 2017-05-25 | $0.8400 | 0.84% |
| 2017-02-24 | $0.8000 | 0.84% |
| 2016-11-18 | $0.8000 | 0.90% |
| 2016-08-19 | $0.8000 | 0.87% |
How JNJ Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 639.90B |
| Enterprise Value | 668.18B |
| Trailing P/E | 30.80 |
| Forward P/E | 20.69 |
| PEG Ratio (5yr) | 4.40 |
| Price/Sales (ttm) | 6.53 |
| Price/Book (mrq) | 7.53 |
| EV/Revenue | 6.82 |
| EV/EBITDA | 19.16 |
Share Statistics
| Avg Vol (3m) | 8.31M |
| Shares Outstanding | 2.41B |
| Float | 2.41B |
| % Held by Insiders | 0.05% |
| % Held by Institutions | 76.82% |
| Short Ratio | 3.04 |
| Short % of Float | 1.27% |
Profitability
| Gross Margin | 68.14% |
| Operating Margin (ttm) | 29.19% |
| Profit Margin | 21.48% |
| Return on Assets (ttm) | 8.60% |
| Return on Equity (ttm) | 25.74% |
Income Statement
| Revenue (ttm) | 97.93B |
| Revenue Growth (yoy) | 6.60% |
| Gross Profit (ttm) | 66.73B |
| EBITDA | 34.87B |
| Net Income (ttm) | 21.04B |
| Diluted EPS (ttm) | 8.62 |
| EPS Growth (yoy) | -0.90% |
Balance Sheet
| Total Cash (mrq) | 20.76B |
| Total Debt (mrq) | 49.04B |
| Debt / Equity (mrq) | 57.71 |
| Current Ratio (mrq) | 1.09 |
| Book Value / Share | 35.28 |
| Operating CF (ttm) | 27.61B |
| Free Cash Flow (ttm) | 16.89B |
Trading & Dividends
| Beta (5Y) | 0.23 |
| 50-Day MA | 243.36 |
| 200-Day MA | 225.41 |
| Fwd Dividend Yield | 201.00% |
| Payout Ratio | 60.79% |
Ownership Breakdown
Institutional 76.82%
Insider 0.05%
Public 23.1%
Short Interest
1.27% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in JNJ in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-20 | BROADHURST VANESSA | Officer | Sale at price 251.27 per share. | 23,054 | $5,792,686 |
| 2026-07-20 | BROADHURST VANESSA | Officer | Conversion of Exercise of derivative security at price 129.51 - 131.94 per share. | 23,054 | $3,014,701 |
| 2026-06-11 | WENGEL KATHRYN E | Chief Technology Officer | Sale at price 241.15 per share. | 10,000 | $2,411,500 |
| 2026-06-11 | WENGEL KATHRYN E | Chief Technology Officer | Conversion of Exercise of derivative security at price 115.67 per share. | 10,000 | $1,156,700 |
| 2026-05-01 | REED JOHN C | Officer | 25,255 | — | |
| 2026-02-27 | DECKER ROBERT J | Officer | Sale at price 247.87 per share. | 4,075 | $1,010,070 |
| 2026-02-27 | DECKER ROBERT J | Officer | Conversion of Exercise of derivative security at price 115.67 per share. | 4,075 | $471,355 |
| 2026-02-20 | SCHMID TIMOTHY | Officer | Sale at price 245.66 per share. | 1,322 | $324,763 |
| 2026-02-18 | SCHMID TIMOTHY | Officer | Sale at price 244.20 - 244.53 per share. | 22,623 | $5,527,506 |
| 2026-02-18 | SCHMID TIMOTHY | Officer | Conversion of Exercise of derivative security at price 115.67 - 129.51 per share. | 29,554 | $2,741,335 |
| 2026-02-17 | SWANSON JAMES D | Chief Technology Officer | Sale at price 242.70 - 243.76 per share. | 62,080 | $15,109,759 |
| 2026-02-17 | BROADHURST VANESSA | Officer | Sale at price 243.39 per share. | 6,197 | $1,508,288 |
| 2026-02-17 | WOLK JOSEPH J | Chief Financial Officer | Sale at price 242.68 - 242.99 per share. | 89,654 | $21,767,827 |
| 2026-02-17 | REED JOHN C | Officer | Sale at price 243.00 per share. | 53,931 | $13,105,233 |
| 2026-02-17 | WOLK JOSEPH J | Chief Financial Officer | Conversion of Exercise of derivative security at price 115.67 - 131.94 per share. | 107,784 | $8,193,223 |
| 2026-02-17 | SWANSON JAMES D | Chief Technology Officer | Conversion of Exercise of derivative security at price 162.75 - 165.89 per share. | 73,140 | $10,202,710 |
| 2026-02-17 | REED JOHN C | Officer | Conversion of Exercise of derivative security at price 156.15 - 157.92 per share. | 54,844 | $8,103,281 |
| 2026-02-13 | FORMINARD ELIZABETH | Officer | 16,381 | — | |
| 2026-02-13 | MULHOLLAND KRISTEN | Officer | 5,006 | — | |
| 2026-02-13 | TAUBERT JENNIFER L | Officer | 32,155 | — | |
| 2026-02-13 | BROADHURST VANESSA | Officer | 10,020 | — | |
| 2026-02-13 | DECKER ROBERT J | Officer | 3,736 | — | |
| 2026-02-13 | WENGEL KATHRYN E | Officer | 15,598 | — | |
| 2026-02-13 | DUATO JOAQUIN BOIX | Chief Executive Officer | 84,710 | — | |
| 2026-02-06 | SCHMID TIMOTHY | Officer | Conversion of Exercise of derivative security at price 101.87 per share. | 15,571 | $1,586,218 |
BROADHURST VANESSA
Officer
Sale at price 251.27 per share.
2026-07-20
23,054 sh
$5,792,686
BROADHURST VANESSA
Officer
Conversion of Exercise of derivative security at price 129.51 - 131.94 per share.
2026-07-20
23,054 sh
$3,014,701
WENGEL KATHRYN E
Chief Technology Officer
Sale at price 241.15 per share.
2026-06-11
10,000 sh
$2,411,500
WENGEL KATHRYN E
Chief Technology Officer
Conversion of Exercise of derivative security at price 115.67 per share.
2026-06-11
10,000 sh
$1,156,700
REED JOHN C
Officer
2026-05-01
25,255 sh
—
DECKER ROBERT J
Officer
Sale at price 247.87 per share.
2026-02-27
4,075 sh
$1,010,070
DECKER ROBERT J
Officer
Conversion of Exercise of derivative security at price 115.67 per share.
2026-02-27
4,075 sh
$471,355
SCHMID TIMOTHY
Officer
Sale at price 245.66 per share.
2026-02-20
1,322 sh
$324,763
SCHMID TIMOTHY
Officer
Sale at price 244.20 - 244.53 per share.
2026-02-18
22,623 sh
$5,527,506
SCHMID TIMOTHY
Officer
Conversion of Exercise of derivative security at price 115.67 - 129.51 per share.
2026-02-18
29,554 sh
$2,741,335
SWANSON JAMES D
Chief Technology Officer
Sale at price 242.70 - 243.76 per share.
2026-02-17
62,080 sh
$15,109,759
BROADHURST VANESSA
Officer
Sale at price 243.39 per share.
2026-02-17
6,197 sh
$1,508,288
WOLK JOSEPH J
Chief Financial Officer
Sale at price 242.68 - 242.99 per share.
2026-02-17
89,654 sh
$21,767,827
REED JOHN C
Officer
Sale at price 243.00 per share.
2026-02-17
53,931 sh
$13,105,233
WOLK JOSEPH J
Chief Financial Officer
Conversion of Exercise of derivative security at price 115.67 - 131.94 per share.
2026-02-17
107,784 sh
$8,193,223
SWANSON JAMES D
Chief Technology Officer
Conversion of Exercise of derivative security at price 162.75 - 165.89 per share.
2026-02-17
73,140 sh
$10,202,710
REED JOHN C
Officer
Conversion of Exercise of derivative security at price 156.15 - 157.92 per share.
2026-02-17
54,844 sh
$8,103,281
FORMINARD ELIZABETH
Officer
2026-02-13
16,381 sh
—
MULHOLLAND KRISTEN
Officer
2026-02-13
5,006 sh
—
TAUBERT JENNIFER L
Officer
2026-02-13
32,155 sh
—
BROADHURST VANESSA
Officer
2026-02-13
10,020 sh
—
DECKER ROBERT J
Officer
2026-02-13
3,736 sh
—
WENGEL KATHRYN E
Officer
2026-02-13
15,598 sh
—
DUATO JOAQUIN BOIX
Chief Executive Officer
2026-02-13
84,710 sh
—
SCHMID TIMOTHY
Officer
Conversion of Exercise of derivative security at price 101.87 per share.
2026-02-06
15,571 sh
$1,586,218